말초혈관 스텐트 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Peripheral Vascular Stents Market size is expected to reach USD 5.25 Billion in 2034 from USD 2.66 Billion (2025) growing at a CAGR of 7.84% during 2026-2034.

The global peripheral vascular stents market has witnessed significant growth due to increasing prevalence of vascular diseases affecting blood vessels outside the heart and brain. Peripheral vascular stents are medical devices used to open narrowed or blocked arteries and improve blood flow. These devices play a crucial role in treating conditions such as peripheral artery disease, which has become more common due to aging populations and lifestyle-related health issues.

Several factors are driving the growth of the peripheral vascular stents market. Rising cases of cardiovascular disorders, diabetes, and obesity have increased the demand for minimally invasive treatment procedures. Technological advancements in stent design, including drug-eluting and self-expanding stents, have improved treatment outcomes and reduced complications. Additionally, increasing awareness about early diagnosis and treatment is supporting market expansion.

Looking ahead, the peripheral vascular stents market is expected to grow as healthcare systems focus on improving treatment options for vascular diseases. Continued research in medical device technologies and expanding access to advanced healthcare services may drive innovation in stent design. Furthermore, growing adoption of minimally invasive procedures will likely support long-term market development.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• Drug Eluting Stents (DEs)
• Bare Metal Stents (BMs)
• Bioabsorbable Stents

By Mode Of Delivery

• Self-Expanding Stents
• Balloon-Expandable Stents

By Product

• Iliac Artery Stents
• Femoral Artery Stents
• Carotid Artery Stents
• Renal Artery Stents
• Other Peripheral Stents

By End-Use

• Hospitals & Cardiac Centers
• Ambulatory Surgical Centers
• Others

COMPANIES PROFILED

• Boston Scientific Inc, Medtronic, Terumo Medical, Abbott, Biotronik, Lifetech, iVascular SLU, Stryker, Cook Medical, Microport Scientific Corporation, Stentys SA, Hellman Friedman Cordis Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL PERIPHERAL VASCULAR STENTS MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Drug Eluting Stents (DEs) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Bare Metal Stents (BMs) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Bioabsorbable Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PERIPHERAL VASCULAR STENTS MARKET: BY MODE OF DELIVERY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Mode Of Delivery
• 5.2. Self-Expanding Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Balloon-Expandable Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PERIPHERAL VASCULAR STENTS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Product
• 6.2. Iliac Artery Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Femoral Artery Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Carotid Artery Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Renal Artery Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Other Peripheral Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PERIPHERAL VASCULAR STENTS MARKET: BY END-USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End-use
• 7.2. Hospitals & Cardiac Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL PERIPHERAL VASCULAR STENTS MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Type
  • 8.2.2 By Mode Of Delivery
  • 8.2.3 By Product
  • 8.2.4 By End-use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Type
  • 8.3.2 By Mode Of Delivery
  • 8.3.3 By Product
  • 8.3.4 By End-use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Type
  • 8.4.2 By Mode Of Delivery
  • 8.4.3 By Product
  • 8.4.4 By End-use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Type
  • 8.5.2 By Mode Of Delivery
  • 8.5.3 By Product
  • 8.5.4 By End-use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Type
  • 8.6.2 By Mode Of Delivery
  • 8.6.3 By Product
  • 8.6.4 By End-use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL PERIPHERAL VASCULAR STENTS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Boston Scientific Inc
  • 10.2.2 Medtronic
  • 10.2.3 Terumo Medical
  • 10.2.4 Abbott
  • 10.2.5 Biotronik
  • 10.2.6 Lifetech
  • 10.2.7 IVascular SLU
  • 10.2.8 Stryker
  • 10.2.9 Cook Medical
  • 10.2.10 Microport Scientific Corporation
  • 10.2.11 Stentys S.A
  • 10.2.12 Hellman & Friedman (Cordis Inc.)